Michael Hallek to CD52 Antigen
This is a "connection" page, showing publications Michael Hallek has written about CD52 Antigen.
Connection Strength
0.025
-
Pharmacokinetics of alemtuzumab and the relevance in clinical practice. Leuk Lymphoma. 2008 Dec; 49(12):2256-62.
Score: 0.025
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.